New Frontiers in Cancer Genomics
Fee may apply
New research shows that genetic variations continue to accrue throughout tumor development. Having the ability to conduct deep sequencing on the healthy and cancerous cells in a patient, at multiple stages of growth and treatment, has led to invaluable findings and new directions for analyses in the field.
This course explores the role of genomics in cancer diagnosis, prognosis and treatment. Providing a greater view of mutations through tumor profiling, more targeted and personalized health care can be administered and positively impact disease outcomes. Discover the latest research advancing the study of cancer and the power of genomics in medical decision making.
This course is an elective course in the Stanford Genetics and Genomics Certificate.
What you will learn
- Assessments of hereditary risk through multi-gene panel screens
- Classifications of cancers by genomic differences
- Evolutions of cancer cells that cause treatment resistance
- New technologies for non-invasive analyses
- Spectrums and sub-types of cancer mutations
Please contact us at 650.263.4700 or
Includes 60 days access to the online course homepage and digital color PDF's of presentations and handouts when available.
*Note: All amounts shown are in USD
60 day access to the online course starts upon payment. The end date of a section of this course does not restrict your access to the course material.
Course materials are available for download from the online videos page. All materials are available for printing and review upon enrollment.
Online participants are asked to complete a final exam at the end of each course to maintain the integrity of the program. A score of 85% must be achieved to successfully pass the exam. A digital record of completion will be emailed to participants when they pass the exam.
It is required that participants complete the course evaluation once they have passed the final exam.